Compare Nucor Corporation (NUE) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nucor Corporation vs Oruka Therapeutics Inc. Common Stock — how do they compare? Nucor Corporation trades at $257.14 (market cap $58.33B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.08B). The key difference: Nucor Corporation is far larger — about 11.5× Oruka Therapeutics Inc. Common Stock's market cap, and Nucor Corporation pays a 0.87% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nucor Corporation for 78 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| NUE | ORKA | |
|---|---|---|
Market Cap | $58.33B | $5.08B |
Volume | 1,032,707 | 685,276 |
Sector | Basic Materials | Health |
52-Week High | $274.74 | $113.08 |
52-Week Low | $131.78 | $26.19 |
Typical Hold Time | 78 Days | 0 Days |
Enterprise Value | $62.74B | $4.21B |
Dividend Yield | 0.87% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nucor (NUE) trades at $253.80, up 0.78% on the day, with a bullish technical signal driven by moving averages and near-term resistance at $254. The stock has shown strong earnings momentum, beating estimates in two of the last three quarters, with Q3 2026 guidance projecting higher earnings. Revenue trends are improving, with 2026 revenue forecast at $36.1B, and the company maintains a solid balance sheet with a debt-to-asset ratio of 20.23% as of 2025. Analyst consensus is a 'Buy' with a $266.88 price target, reflecting optimism around steel pricing and operational execution.
The outlook for NUE is positive, supported by earnings beats, favorable steel market dynamics, and a shareholder-friendly dividend policy. Key risks include competitive pressures from new capacity, volatility in steel prices, and macroeconomic sensitivity. The stock offers upside to consensus targets but requires monitoring of cost pressures and industry supply changes.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nucor Corporation
Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products and raw materials, the steel mills segment derives maximum revenue.
Read more on NUE →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
